Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 20.4T | 16.9T | 14.6T | 13.2T |
Cost of revenue | 16.0T | 13.6T | 11.6T | 10.4T |
Gross profit | 4.4T | 3.3T | 3.0T | 2.7T |
Operating expense | ||||
Research & development | 923.6B | 880.9B | 787.1B | 738.9B |
Selling general and admin | 2.1T | 1.7T | 1.3T | 1.3T |
Other operating expenses | — | — | — | — |
Operating income | 1.4T | 780.8B | 871.2B | 660.2B |
Non operating interest income | ||||
Income | 173.7B | 73.1B | 25.6B | 19.8B |
Expense | 59.6B | 36.1B | 16.9B | 13.9B |
Other income expense | 186.8B | 79.2B | 197.5B | 265.0B |
Pretax income | 1.6T | 879.6B | 1.1T | 914.1B |
Tax provision | 459.8B | 162.3B | 309.5B | 218.6B |
Net income | 1.2T | 717.3B | 760.7B | 695.4B |
Basic EPS | 677.6 | 409.9 | 411.1 | 380.8 |
Diluted EPS | 677.6 | 409.9 | 411.1 | 380.8 |
Basic average shares | 11.9B | 12.6B | 12.8B | 12.8B |
Diluted average shares | 11.9B | 12.6B | 12.8B | 12.8B |
EBITDA | 2.4T | 1.7T | 1.7T | 1.6T |
Net income from continuing op. | 1.6T | 879.6B | 1.1T | 914.1B |
Minority interests | -75.4B | -65.9B | -53.6B | -38.0B |
Preferred stock dividends | — | — | — | — |